-58.2%
CRWV vs GSK
+14.9%
-73.1%
-64.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -9.9% | +5.0% | -14.9% | -5.8% |
| 7D | -24.3% | +4.9% | -29.2% | -20.8% |
| 30D | -44.6% | +9.9% | -54.5% | -39.7% |
| 3M | -47.3% | +0.2% | -47.5% | -45.4% |
| 6M | -61.4% | +2.3% | -63.7% | -59.3% |
| YTD | -32.4% | +7.1% | -39.4% | -25.5% |
| 1Y | -58.2% | +13.1% | -71.3% | -52.2% |
| All | -58.2% | +14.9% | -73.1% | -52.2% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling